COMEMRIA Trademark

Trademark Overview

On Friday, October 25, 2013, a trademark application was filed for COMEMRIA with the United States Patent and Trademark Office. The USPTO has given the COMEMRIA trademark a serial number of 86101852. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Glaxo Group Limited. The COMEMRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
comemria

General Information

Serial Number86101852
Word MarkCOMEMRIA
Filing DateFriday, October 25, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number5211484
Registration DateTuesday, May 30, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "COMEMRIA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 12, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 12, 2017TEAS DELETE 1(B) BASIS RECEIVED
Saturday, September 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2016SOU EXTENSION 4 GRANTED
Monday, September 12, 2016SOU EXTENSION 4 FILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Saturday, March 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2016SOU EXTENSION 3 GRANTED
Thursday, March 3, 2016SOU EXTENSION 3 FILED
Thursday, March 3, 2016SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2015SOU EXTENSION 2 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 2 FILED
Thursday, September 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 31, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 27, 2015SOU EXTENSION 1 GRANTED
Friday, March 27, 2015SOU EXTENSION 1 FILED
Friday, March 27, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 15, 2014ASSIGNED TO LIE
Friday, June 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 27, 2014EXAMINER'S AMENDMENT ENTERED
Friday, June 27, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 27, 2014EXAMINERS AMENDMENT E-MAILED
Friday, June 27, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 25, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 25, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, January 11, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, January 11, 2014LETTER OF SUSPENSION E-MAILED
Saturday, January 11, 2014SUSPENSION LETTER WRITTEN
Friday, January 10, 2014ASSIGNED TO EXAMINER
Friday, November 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 29, 2013NEW APPLICATION ENTERED

Related Keywords

comemria pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological